The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $206.25

Today's change-2.37 -1.14%
Updated May 29 2:39 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $206.25

Today's change-2.37 -1.14%
Updated May 29 2:39 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down (U.S.)$2.37

Illumina Inc is lower today, dropping (U.S.)$2.37 or 1.14% to (U.S.)$206.25. Over the last five days, shares have gained 0.61% and are currently 3.32% off of the 52-week high. Shares have outperformed the S&P 500 by 19.19% during the last year.

Key company metrics

  • Open(U.S.) $208.62
  • Previous close(U.S.) $208.62
  • High(U.S.) $208.90
  • Low(U.S.) $205.42
  • Bid / Ask(U.S.) $206.15 / (U.S.) $206.39
  • YTD % change+11.74%
  • Volume522,674
  • Average volume (10-day)1,113,391
  • Average volume (1-month)1,223,357
  • Average volume (3-month)1,186,848
  • 52-week range(U.S.) $145.12 to (U.S.) $213.33
  • Beta0.90
  • Trailing P/E71.21×
  • P/E 1 year forward60.87×
  • Forward PEG2.87×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.90
Updated May 29 2:39 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.73%

Based on its net profit margin of 21.73%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.68%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 29, 201503/29/2015Dec 28, 201412/28/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014
Revenue539512481448
Total other revenue--------
Total revenue539512481448
Gross profit375385334301
Total cost of revenue164127147147
Total operating expense362309361347
Selling / general / administrative116122120115
Research & development921438582
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-9-83103
Other operating expenses, total--000
Operating income176203119100
Interest income (expense), net non-operating-11-11-11-10
Gain (loss) on sale of assets--------
Other--------
Income before tax17819211260
Income after tax1371539347
Income tax, total41391914
Net income1371539347
Total adjustments to net income--------
Net income before extra. items1371539347
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1371539347
Inc. avail. to common incl. extra. items1371539347
Diluted net income1371539347
Dilution adjustment--------
Diluted weighted average shares149149148149
Diluted EPS excluding extraordinary itemsvalue per share0.921.030.630.31
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.870.590.690.33